Clinical Trial Update: Flaxseed Modulates Inflammation and Oxidative Stress in CF [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating flaxseed's effects on inflammation and oxidative stress in cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Flaxseed (Linum usitatissimum seed)

Snippet

Sponsor: University of Pennsylvania | Conditions: Cystic Fibrosis, Oxidative Stress | Phase 1 | Status: COMPLETED